• Contact ArQule
  • About ArQule
  • Product R & D
  • Clinical Trials
  • Investors and Media
    • Press Releases
    • Events
    • Corporate Presentation
    • Recent Data Presentations
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Contact Us
  • Careers
Shareholder Tools
Briefcase Shareholder Briefcase
Email Alerts Email Alerts
Download Center Download Library
snapshot Snapshot
Mobile Investor Mobile Investor
RSS RSS News Feeds
 
Search Investor Relations

Print   Email   Share
Share this on: Close window
delicious delicious
Digg Digg
Facebook Facebook
LinkedIn LinkedIn
Twitter Twitter
Yahoo Buzz Yahoo! Buzz
What is this?

Home : Investors and Media

Investors and Media

Our mission as a biotechnology company is to research, develop and commercialize a next-generation of small molecule cancer therapeutics. We are combining innovative, proprietary anti-cancer technology with world-class chemistry capabilities to generate drug candidates that target multiple tumor types, act selectively against cancer cells and are well tolerated by patients. Our lead products are in clinical development, and our research pipeline targets multiple molecules with established roles and therapeutic potential in cancer.

We are headquartered and operate research facilities and development programs in Woburn, Massachusetts.

 

Recent Releases

May 17, 2012
Positive Phase 2 Clinical Data with Tivantinib in Hepatocellular Carcinoma to Be Highlighted in Oral Presentation at 2012 Annual Meeting of American Society of Clinical Oncology

May 3, 2012
ArQule Reports First Quarter 2012 Financial Results



Recent Events

May 3, 2012 at 9:00 AM ET
Q1 2012 ArQule, Inc. Earnings Conference Call




Corporate Presentation

Apr 17, 2012
PDF View Presentation  3.2 MB   Add to Briefcase


Stock Chart Stock Quote
Stock price graph
3 Mo.   6 Mo.   1 Yr.
ArQule NASDAQ: ARQL
Price: 6.20
Change: - 0.53
Day High: 6.80
Day Low: 6.12
Volume: 842,500
Delayed at least 20 minutes.
Provided by eSignal.


Transfer Agent
American Stock and Transfer
41 Wall Street
New York City, NY 10005
Phone: 212-936-5100

© ArQule, 2012 | Terms and Conditions: Purchasing | Terms of Use